{"id":"NCT00929864","sponsor":"Bristol-Myers Squibb","briefTitle":"Abatacept Versus Adalimumab Head-to-Head","officialTitle":"A Randomized, Head-to-Head, Single-Blind Study to Compare the Efficacy and Safety of Subcutaneous Abatacept Versus Subcutaneous Adalimumab, Both With Background Methotrexate, in Biologic-Naive Subjects With Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10","primaryCompletion":"2011-10","completion":"2012-11","firstPosted":"2009-06-30","resultsPosted":"2014-01-03","lastUpdate":"2014-02-04"},"enrollment":869,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Abatacept","otherNames":["Orencia","BMS-188667"]},{"type":"DRUG","name":"Adalimumab","otherNames":["Humira"]}],"arms":[{"label":"Abatacept","type":"ACTIVE_COMPARATOR"},{"label":"Adalimumab","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is demonstrate that subcutaneous abatacept is non-inferior (no worse than) to subcutaneous adalimumab in the treatment of subjects with rheumatoid arthritis who are biologic naive","primaryOutcome":{"measure":"The Proportion of Participants Meeting the American College of Rheumatology (ACR) Criteria of 20% Improvement (ACR20) After 12 Months of Treatment - Intent to Treat Population","timeFrame":"Day 1 to Day 365","effectByArm":[{"arm":"Abatacept","deltaMin":64.8,"sd":null},{"arm":"Adalimumab","deltaMin":63.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":83,"countries":["United States","Argentina","Canada","Chile","Peru"]},"refs":{"pmids":["34878629","31819995","31642045","27111089","27110385","26473625","26359449","23962455","23169319"],"seeAlso":["http://www.bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":43,"n":318},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Bronchitis","Sinusitis","Back pain"]}}